Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology - Simpson, D M; Blitzer, A; Brashear, A (Neurology, 2008)
, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.